MHRA provides Marketing Authorisation for Pegcetacoplan (Aspaveli)
Posted on
Following a Great Britain Marketing Authorisation being provided by the Medicines Healthcare Regulatory Authority (MHRA) for Pegcetacoplan (Aspaveli), NICE published its Final Guidance on Pegcetacoplan for treating PNH on 9 March 2022. […]
Read more About MHRA provides Marketing Authorisation for Pegcetacoplan (Aspaveli)